RESTYLANE INJECTABLE GEL
FDA premarket approval P040024/S005 · decided 2006-03-03
Approval details
- PMA number
- P040024
- Supplement
- S005
- Supplement type
- Special (Immediate Track)
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- RESTYLANE INJECTABLE GEL
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2006-02-02
- Decision date
- 2006-03-03
- Days to decision
- 29 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- APPROVAL FOR QUALITY CONTROL CHANGE THAT PROVIDES FOR ADDITIONAL ASSURANCE OF THE PURITY OF RESTYLANE INJECTABLE GEL DEVICE REGARDING ENDOTOXIN LEVEL.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.